On August 5, 2020, the Federal Drug Administration (FDA) announced a voluntary recall by Ferring US on all lots of DDAVP (desmopressin acetate) nasal spray (10mcg/0.1mL, 5mL), desmopressin acetate nasal spray (10mcg/0.1mL, 5mL), and STIMATE nasal spray (1.5mg/mL, 2.5mL). On August 5, 2020, CSL Behring, the manufacturer of STIMATE ® (desmopressin acetate) Nasal Spray, issued a voluntary recall of all lots on the market. December 10, 2020 Thermo Tents Recalls Mór Series Tents Due to Fire Hazard; Tents are Mislabeled as Fire Retardant Sold at: Walmart and Walmart.com. Ferring US issues Voluntary Nationwide Recall of DDAVP® Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, STIMATE® Nasal Spray 1.5 … The recall began January 15, 2020. The recall covers certain 2012 and 2013 Sorento SUVs, 2012 through 2015 Forte and Forte Koup cars, and 2011 through 2013 Optima Hybrid cars. Statement from CSL Behring: Ferring Pharmaceuticals, Inc., is initiating a precautionary voluntary recall of all batches of Stimate® Nasal Spray (desmopressin acetate) 1.5 mg/mL. Click here for Medical Advisory #426. December 2, 2020 Huffy Recalls Torex Ride-on Toy UTVs Due to Injury Hazard December 9, 2020 Fiskars Brands Recalls 16 Foot Pole Saw/Pruners Due to Laceration Hazard Sold at: Walmart.com. According to the recall, these products are being recalled because testing revealed the presence of higher than specified amounts of a drug called desmopressin. CSL Behring and Ferring Pharmaceuticals have announced additional information about a recent recall of lots of Stimate that was originally issued July 21, 2020. Aug 6, 2020 10:01 AM Recall of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, STIMATE Nasal Spray 1.5 mg/mL by Ferring Pharmaceuticals US due to superpotency. CDC Seeks Perspectives on Living with Chronic Pain Our list of Recalls includes automotive, appliance, food, technology, clothing, and more. On October 28, 2020, this Safety Recall was amended to include a total of approximately 2,760,500 vehicles. Three weeks after recalling numerous lots of desmopressin nasal sprays in the UK and a number of other countries, Ferring has issued a recall of all lots of DDAVP 10 mcg/0.1ml, Stimate 1.5 mg/ml, and generic desmopressin 10 mcg/0.1ml nasal sprays in the US “due to superpotency or amounts of desmopressin higher than specified.” The recall includes 6 lots of DDAVP, 15 lots of Stimate, and … August 5, 2020 - Ferring Pharmaceuticals announced a voluntary, consumer-level recall of several lots of DDAVP®, desmopressin acetate, and Stimate® nasal spray products due to superpotency or amounts of desmopressin higher than specified. On August 12, 2020, CSL Behring issued a consumer-level recall of all lots on the market of STIMATE® Nasal Spray 1.5 mg/mL NDC # 00053-6871-00 manufactured by Ferring Pharmaceuticals and distributed and sold by CSL Behring. Reason: Product may contain undeclared MILK, and if eaten, could result in a severe allergic reaction to those sensitive to MILK. Stimate Nasal Spray is owned and manufactured by Ferring Pharmaceuticals Inc., and is distributed and sold in the United States by CSL Behring. August 6, 2020 Ohio Legal Updates, ... Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL. Find Recalls from December 2020 on ConsumerAffairs. These products are being recalled due to superpotency or amounts of desmopressin higher than specified. FRITO LAY PARTY MIX 28CT, 27.25 OZ. An important update regarding the pharmacy level product recall of Stimate (desmopressin) nasal spray. August 05, 2020 -- Ferring Pharmaceuticals US is voluntarily recalling all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL listed in the table below to the consumer level. (July 22, 2020, updated August 15, 2020) Last month, the Coalition for Hemophilia B reported on a voluntary recall of specific lots of Stimate desmopressin acetate nasal spray manufactured by Ferring Pharmaceuticals and distributed in the United States by CSL Behring. A3: When this Safety Recall was first announced on January 13, 2020, there were approximately 564,300 vehicles covered. CSL Behring and Ferring Pharmaceuticals, Inc have responded to the joint NHF-NHF letter of July 22, 2020, regarding a recent recall of Stimate (desmopressin) nasal spray. This recall is due to superpotency, or amounts of desmopressin in … Ferring Pharmaceuticals announced it was extending the recall of Stimate (desmopressin) to the consumer/user level. After further collaboration with the FDA, Ferring is now extending the recall to the consumer … We have learned of a pharmacy level product recall of Stimate (desmopressin) nasal spray manufactured by Ferring Pharmaceuticals, and distributed in the U.S. by CSL Behring. Ferring Pharmaceuticals US announced a voluntary, nationwide recall of DDAVP nasal spray 10 mcg/0.1mL, desmopressin acetate nasal spray 10 mcg/0.1mL, and STIMATE nasal spray 1.5 mg/mL after routine testing found levels of desmopressin higher than specified. Recalled on August-25-2020. Ferring US issues Voluntary Nationwide Recall of DDAVP® Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, STIMATE® Nasal Spray 1.5 mg/mL Due to Superpotency. This recall was issued due to superpotency or amounts of desmopressin higher than specified. Immediately following the issuance of medical advisories to the community regarding the recall of Stimate® (desmopressin nasal spray) a product used to control bleeding in patients with von Willebrand disease and hemophilia A, the National Hemophilia Foundation and Hemophilia Federation of America sent a joint letter to CSL Behring, which sells and distributes Stimate® in the US and Ferring … Find 2020 Ford F-150 recalls information, reported by the NHTSA, and we will help you find a nearby service center where you can get your car fixed. Notes: Owners may also contact the National Highway Traffic Safety Administration Vehicle Safety Hotline at 1-888-327-4236 (TTY 1-800-424-9153), or go to www.safercar.gov. To provide better service in alerting the American people to unsafe, hazardous or defective products, six federal agencies with vastly different jurisdictions have joined together to create www.recalls.gov -- a "one stop shop" for U.S. Government recalls. On March 4, 2020, this Safety Recall was amended and covered a total of approximately 1,433,050 vehicles. Stimate is manufactured by Ferring Pharmaceuticals Inc. and is distributed and sold in the United States by CSL Behring. The risks associated with superpotency relate to abnormally low levels of sodium in the blood, which could eventually lead to … Also, get recall information on car seats, tires and equipment. More on the FDA website . It is possible that the product may contain elevated amounts of desmopressin acetate, the active pharmaceutical ingredient, and benzalkonium chloride, a preservative. Owners may contact Merritt customer service at 1-317-409-0146. Affects Food 4 Less stores. The recalled products are … August 11, 2020 Stimate Recall Update – CSL Behring & Ferring Pharmaceuticals Response to HFA-NHF Letter, Voluntary Recall Due to “Superpotency” Ferring Pharmaceuticals issued a voluntary recall of Stimate (desmopressin) nasal spray due to “superpotency” – in other words, amounts of desmopressin being higher than specified. Aug 13, 2020. In mid-August, the European Haemophilia Consortium (EHC) communicated an international recall of all FerringPharmaceuticals Limited nasal sprays containing desmopressin, including Octim®, Octostim®, Desmospray®, DDAVP Spray® and Stimate®, and reported that this may lead to shortages over the course of 2020. On August 26, 2020, the U.S. Food and Drug Administration (FDA) announced that Ferring Pharmaceuticals US is voluntarily recalling all lots on the market of DDAVP® Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL and STIMATE® Nasal Spray 1.5 mg/mL listed at the website below as a Class I Recall. If Stimate is part of your treatment plan, please contact your medical team for further discussion regarding your individual care. On July 21, CSL Behring and Ferring Pharmaceuticals announced a recall of multiple lots of Stimate (desmopressin), in the United States and in other countries around the world. These out of specification results … Stimate® Batch Numbers: See chart below NDC Number: 0053-6871-00 Dear Customer: This updated letter is to provide you with additional information regarding the Stimate® Nasal Spray recall communication that was sent to you on July 21, 2020. August 5, 2020. On August 5, 2020, Ferring Pharmaceuticals announced a recall of three nasal sprays due to superpotency of the ingredients. St imate® Nasal Spray is owned and manufactured by Ferring A recall on Ferring Pharmaceuticals ‘ intranasal desmopressin compounds — used to treat mild to moderate hemophilia A and von Willebrand disease type 1 — is expected to affect the availability of these products until at least mid- to late-2021, according to an advisory from the World Federation of Hemophilia. This marks an expansion of Ferring’s initial July 2020 plans to conduct a narrower pharmacy-level recall. July 21, 2020 Ferring Pharmaceuticals has issued a voluntary recall of all Stimate (desmopressin acetate) nasal spray 1.5mg/mL distributed and sold by CSL Behring LLC. Use our VIN lookup tool to check for recalls on your car, or search by make and model. Recalled on August-28-2020. Read more about Stimate Recall Update; August 6, 2020. All lots of DDAVP Nasal Spray 10 mcg/0.1 ml, Desmopressin Acetate nasal Spray 10 mcg/0.1 ml, and STIMATE Nasal Spray 1.5 mg/ml listed in the table are recalled. October 23, 2020 This recall was issued due to superpotency or amounts of desmopressin higher than specified, … Please read if you use Stimate. August 05, 2020 -- Ferring Pharmaceuticals US is voluntarily recalling all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL listed in the table below to the consumer level.